Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load
- Status
- WITHDRAWN
- Phase
- PHASE2
A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Montelukast in Asthmatic Children With and Without Food Allergy
- Status
- COMPLETED
- Phase
- PHASE4
Glasgow Asthma and Allergy Study
- Status
- COMPLETED
- Phase
- N/A
Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
- Status
- COMPLETED
- Phase
- N/A
An Open-label Study to Identify Molecular Markers of Steroid Resistance
- Status
- TERMINATED
- Phase
- PHASE4
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
- Status
- TERMINATED
- Phase
- PHASE1
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
- Status
- COMPLETED
- Phase
- PHASE1
Delayed Start to Ovarian Stimulation
- Status
- TERMINATED
- Phase
- PHASE4
A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)
- Status
- TERMINATED
- Phase
- PHASE4
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
- Status
- COMPLETED
- Phase
- PHASE3
ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
- Status
- COMPLETED
- Phase
- N/A
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir
- Status
- WITHDRAWN
- Phase
- N/A